InsidersTradesSigma
argenx SE Stock: price and management transactions · Netherlands · AFM
Follow the argenx SE share price and the full insider trade history of the company, a listed issuer based in Netherlands. Shares trade on NL NL, under the oversight of AFM. Operating in the Healthcare & Pharma sector, argenx SE has recorded 270 insider filings. Market capitalisation: €58.7bn. The latest transaction was filed on 3 July 2026 (Mixed). Among the most active insiders: T.J.M. van Hauwermeiren. The full history is free.
270
Insider Decl.
0
Thresholds
€175,418
69 ops.
Buy Volume
€36m
57 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate argenx SE Buy (bullish), based on 23 analysts. Average price target: US$1,051.14.
31Σ signal
Fundamental score
Ranked 6,997 of 25,484 companies
63.0
score / 100
Value32
Quality94
FCF yld1.0%
Earn yld2.3%
EV/EBITDA43.7x
ROE·
Gross mgn89%
Net mgn31%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 July 2026
Declarations270 total
-44 shares0Restricted Stock UnitAFM:196579
-110 shares0Restricted Stock UnitAFM:196555
-87 shares0Restricted Stock UnitAFM:196556
-110 shares0Restricted Stock UnitAFM:196563
-87 shares0Restricted Stock UnitAFM:196567
-703 shares0Restricted Stock UnitAFM:196327
-703 shares0Restricted Stock UnitAFM:196329
-703 shares0Restricted Stock UnitAFM:196330
-703 shares0Restricted Stock UnitAFM:196331
-703 shares0Restricted Stock UnitAFM:196332
00Restricted Stock UnitAFM:196324
-703 shares0Restricted Stock UnitAFM:196325
-9,847 shares0Restricted Stock UnitAFM:193107
-132 shares0Restricted Stock UnitAFM:191191
-107 shares@ €660.3923.2% of flowGewoon aandeelAFM:188922
0@ €270.209.3% of flowPersoneelsoptieAFM:188811
-65,000 shares@ €43.1612.6% of flowPersoneelsoptieAFM:188266
25 of 270 declarations
About argenx SE
argenx SE is a biopharmaceutical company focused on developing therapeutic antibodies for treating autoimmune diseases and cancers. It is listed on the Euronext Amsterdam market.
